AIM logo

AIM ImmunoTech (AIM) Shareholders Equity

Annual Shareholders Equity

$10.23 M
-$28.23 M-73.40%

31 December 2023

AIM Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$2.91 M
-$3.19 M-52.28%

30 September 2024

AIM Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AIM Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-73.4%-87.1%
3 y3 years-83.3%-95.3%
5 y5 years+97.8%-79.0%

AIM Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-83.3%at low-95.3%at low
5 y5 years-83.3%+97.8%-95.9%at low
alltimeall time-83.3%+181.9%-95.9%+38.7%

AIM ImmunoTech Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$2.91 M(-52.3%)
June 2024
-
$6.10 M(+26.4%)
Mar 2024
-
$4.83 M(-52.8%)
Dec 2023
$10.23 M(-73.4%)
$10.23 M(-54.7%)
Sept 2023
-
$22.60 M(-25.0%)
June 2023
-
$30.14 M(-13.9%)
Mar 2023
-
$34.99 M(-9.0%)
Dec 2022
$38.47 M(-32.4%)
$38.47 M(-9.9%)
Sept 2022
-
$42.70 M(-12.5%)
June 2022
-
$48.78 M(-8.5%)
Mar 2022
-
$53.30 M(-6.3%)
Dec 2021
$56.88 M(-7.2%)
$56.88 M(-8.3%)
Sept 2021
-
$62.05 M(-5.3%)
June 2021
-
$65.53 M(-7.7%)
Mar 2021
-
$70.97 M(+15.8%)
Dec 2020
$61.29 M(+356.0%)
$61.29 M(+0.3%)
Sept 2020
-
$61.11 M(+30.0%)
June 2020
-
$46.99 M(+33.8%)
Mar 2020
-
$35.11 M(+161.2%)
Dec 2019
$13.44 M(+159.8%)
$13.44 M(-2.9%)
Sept 2019
-
$13.84 M(+111.4%)
June 2019
-
$6.55 M(+66.6%)
Mar 2019
-
$3.93 M(-24.0%)
Dec 2018
$5.17 M(-40.5%)
$5.17 M(-19.6%)
Sept 2018
-
$6.44 M(-29.2%)
June 2018
-
$9.10 M(-10.8%)
Mar 2018
-
$10.20 M(+17.2%)
Dec 2017
$8.70 M(-43.8%)
$8.70 M(-13.3%)
Sept 2017
-
$10.04 M(-2.8%)
June 2017
-
$10.33 M(-20.2%)
Mar 2017
-
$12.95 M(-16.5%)
Dec 2016
$15.50 M(-23.9%)
$15.50 M(-6.8%)
Sept 2016
-
$16.63 M(-4.9%)
June 2016
-
$17.49 M(-5.0%)
Mar 2016
-
$18.41 M(-9.6%)
Dec 2015
$20.37 M(-18.5%)
$20.37 M(-12.1%)
Sept 2015
-
$23.17 M(-13.4%)
June 2015
-
$26.76 M(-0.8%)
Mar 2015
-
$26.97 M(+7.9%)
Dec 2014
$25.00 M(-14.7%)
$25.00 M(-5.2%)
Sept 2014
-
$26.36 M(-10.2%)
June 2014
-
$29.37 M(-8.2%)
Mar 2014
-
$31.99 M(+9.2%)
Dec 2013
$29.30 M(-34.5%)
$29.30 M(-8.9%)
Sept 2013
-
$32.15 M(-11.0%)
June 2013
-
$36.14 M(-12.7%)
Mar 2013
-
$41.38 M(-7.4%)
Dec 2012
$44.70 M(+17.7%)
$44.70 M(+22.1%)
Sept 2012
-
$36.61 M(+9.2%)
June 2012
-
$33.53 M(-7.2%)
Mar 2012
-
$36.13 M(-4.8%)
Dec 2011
$37.97 M(-17.4%)
$37.97 M(-6.4%)
Sept 2011
-
$40.57 M(-7.1%)
June 2011
-
$43.67 M(-5.0%)
Mar 2011
-
$45.95 M(0.0%)
Dec 2010
$45.95 M
$45.95 M(-14.0%)
Sept 2010
-
$53.40 M(-4.1%)
June 2010
-
$55.69 M(-4.6%)
DateAnnualQuarterly
Mar 2010
-
$58.40 M(-0.5%)
Dec 2009
$58.70 M(+408.4%)
$58.70 M(-11.5%)
Sept 2009
-
$66.31 M(+44.4%)
June 2009
-
$45.91 M(+361.6%)
Mar 2009
-
$9.95 M(-13.9%)
Dec 2008
$11.54 M(-44.9%)
$11.54 M(-9.7%)
Sept 2008
-
$12.78 M(-17.9%)
June 2008
-
$15.56 M(-14.3%)
Mar 2008
-
$18.16 M(-13.3%)
Dec 2007
$20.95 M(-15.3%)
$20.95 M(-10.0%)
Sept 2007
-
$23.29 M(-12.8%)
June 2007
-
$26.72 M(-2.6%)
Mar 2007
-
$27.42 M(+10.8%)
Dec 2006
$24.75 M(+32.9%)
$24.75 M(+15.2%)
Sept 2006
-
$21.48 M(-10.0%)
June 2006
-
$23.87 M(-12.1%)
Mar 2006
-
$27.17 M(+45.9%)
Dec 2005
$18.63 M(-13.6%)
$18.63 M(+35.7%)
Sept 2005
-
$13.73 M(-6.8%)
June 2005
-
$14.73 M(-14.7%)
Mar 2005
-
$17.27 M(-19.9%)
Dec 2004
$21.56 M(+133.1%)
$21.56 M(-5.1%)
Sept 2004
-
$22.71 M(+61.7%)
June 2004
-
$14.05 M(+51.2%)
Mar 2004
-
$9.29 M(+0.5%)
Dec 2003
$9.25 M(+154.8%)
$9.25 M(+25.7%)
Sept 2003
-
$7.36 M(+6.1%)
June 2003
-
$6.94 M(+50.7%)
Mar 2003
-
$4.60 M(+26.8%)
Dec 2002
$3.63 M(-66.3%)
$3.63 M(-27.2%)
Sept 2002
-
$4.98 M(-26.2%)
June 2002
-
$6.75 M(-27.9%)
Mar 2002
-
$9.36 M(-13.0%)
Dec 2001
$10.76 M(-7.0%)
$10.76 M(+56.8%)
Sept 2001
-
$6.86 M(-16.4%)
June 2001
-
$8.21 M(-12.2%)
Mar 2001
-
$9.35 M(-19.2%)
Dec 2000
$11.57 M(-8.9%)
$11.57 M(-8.4%)
Sept 2000
-
$12.64 M(-9.9%)
June 2000
-
$14.03 M(-5.7%)
Mar 2000
-
$14.88 M(+17.2%)
Dec 1999
$12.70 M(-16.4%)
$12.70 M(+41.1%)
Sept 1999
-
$9.00 M(-11.8%)
June 1999
-
$10.20 M(-16.4%)
Mar 1999
-
$12.20 M(-19.7%)
Dec 1998
$15.20 M(+42.1%)
$15.20 M(-5.6%)
Sept 1998
-
$16.10 M(+98.8%)
June 1998
-
$8.10 M(-13.8%)
Mar 1998
-
$9.40 M(-12.1%)
Dec 1997
$10.70 M(+81.4%)
$10.70 M(+409.5%)
Sept 1997
-
$2.10 M(-41.7%)
June 1997
-
$3.60 M(-23.4%)
Mar 1997
-
$4.70 M(-20.3%)
Dec 1996
$5.90 M(+34.1%)
$5.90 M(-18.1%)
Sept 1996
-
$7.20 M(+200.0%)
June 1996
-
$2.40 M(-35.1%)
Mar 1996
-
$3.70 M(-15.9%)
Dec 1995
$4.40 M
$4.40 M

FAQ

  • What is AIM ImmunoTech annual stockholders equity?
  • What is the all time high annual shareholders equity for AIM ImmunoTech?
  • What is AIM ImmunoTech annual shareholders equity year-on-year change?
  • What is AIM ImmunoTech quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly shareholders equity year-on-year change?

What is AIM ImmunoTech annual stockholders equity?

The current annual shareholders equity of AIM is $10.23 M

What is the all time high annual shareholders equity for AIM ImmunoTech?

AIM ImmunoTech all-time high annual stockholders equity is $61.29 M

What is AIM ImmunoTech annual shareholders equity year-on-year change?

Over the past year, AIM annual stockholders equity has changed by -$28.23 M (-73.40%)

What is AIM ImmunoTech quarterly stockholders equity?

The current quarterly shareholders equity of AIM is $2.91 M

What is the all time high quarterly shareholders equity for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly stockholders equity is $70.97 M

What is AIM ImmunoTech quarterly shareholders equity year-on-year change?

Over the past year, AIM quarterly stockholders equity has changed by -$19.69 M (-87.12%)